AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24880843 — intervention group
Group type: EXPERIMENTAL
Intervention: Aligners for distalization
Number of subjects: 30
Study 22326605 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 12
Study 22326605 — intervention group
Group type: COMPARATOR
Intervention: Control group (11 severely obese patients with asthma)
Number of subjects: 12
Study 20101064 — intervention group
Group type: EXPERIMENTAL
Intervention: efavirenz 600 mg mixed with applesauce
Number of subjects: 24
Study 20101064 — intervention group
Group type: EXPERIMENTAL
Intervention: efavirenz 600 mg mixed with grape jelly
Number of subjects: 24
Study 20101064 — intervention group
Group type: EXPERIMENTAL
Intervention: efavirenz 600 mg mixed with yogurt
Number of subjects: 24
Study 20101064 — intervention group
Group type: EXPERIMENTAL
Intervention: efavirenz 600 mg mixed with infant formula
Number of subjects: 24
Study 20101064 — intervention group
Group type: COMPARATOR
Intervention: efavirenz 600 mg intact capsules under fasting conditions
Number of subjects: 24
Study 17621027 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexanabinol
Number of subjects: 861
Study 16723021 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone based intervention group
Number of subjects: 0
Study 16723021 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet based intervention group
Number of subjects: 0
Study 16723021 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 12438046 — intervention group
Group type: EXPERIMENTAL
Intervention: On-site mobile mammography and health education
Number of subjects: 499
Study 12438046 — intervention group
Group type: COMPARATOR
Intervention: Health education only
Number of subjects: 499
Study 10099127 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal immunization
Number of subjects: 0
Study 10099127 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal immunization
Number of subjects: 0
Study 10099127 — intervention group
Group type: COMPARATOR
Intervention: Oral immunization
Number of subjects: 0
Study 8746604 — intervention group
Group type: EXPERIMENTAL
Intervention: cilazapril 5 mg once a day
Number of subjects: 40
Study 8746604 — intervention group
Group type: COMPARATOR
Intervention: hydrochlorothiazide 25 mg once a day
Number of subjects: 40
Study 2036929 — intervention group
Group type: EXPERIMENTAL
Intervention: Double stapling technique
Number of subjects: 70
Study 2036929 — intervention group
Group type: COMPARATOR
Intervention: Single stapling technique
Number of subjects: 70
Study 7149897 — intervention group
Group type: EXPERIMENTAL
Intervention: Social skills training alone
Number of subjects: 22
Study 7149897 — intervention group
Group type: EXPERIMENTAL
Intervention: Social skills training combined with cognitive modification
Number of subjects: 22
Study 7149897 — intervention group
Group type: COMPARATOR
Intervention: Social skills training (both conditions)
Number of subjects: 22
Study 7149897 — intervention group
Group type: COMPARATOR
Intervention: Untreated targets
Number of subjects: 22
Study 31215430 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-menu format
Number of subjects: 88
Study 31215430 — intervention group
Group type: COMPARATOR
Intervention: Type A format
Number of subjects: 88
Study 28802288 — intervention group
Group type: EXPERIMENTAL
Intervention: Pectin-supplemented enteral nutrition (PEC/EN)
Number of subjects: 125
Study 28802288 — intervention group
Group type: COMPARATOR
Intervention: Enteral nutrition (EN)
Number of subjects: 125
Study 25820146 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) iv (500 UI/kg, repeated at 24 and 48 hours)
Number of subjects: 19
Study 25820146 — intervention group
Group type: COMPARATOR
Intervention: Methylprednisolone (MP) according to the NASCIS III protocol
Number of subjects: 19
Study 25820146 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO)
Number of subjects: 19
Study 25820146 — intervention group
Group type: COMPARATOR
Intervention: Methylprednisolone (MP)
Number of subjects: 19
Study 25820146 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) and Methylprednisolone (MP)
Number of subjects: 19
Study 23671895 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline 10mg daily
Number of subjects: 62
Study 23671895 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline 10mg daily with Pindolol 5mg twice daily
Number of subjects: 62
Study 23671895 — intervention group
Group type: COMPARATOR
Intervention: Surrogate placebo (Loratadine 10mg daily)
Number of subjects: 62
Study 21489084 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin analogues (various regimens: basal, prandial, biphasic, basal-bolus)
Number of subjects: 38803
Study 21489084 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin analogues (basal-bolus regimen)
Number of subjects: 38803
Study 21489084 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin analogues (overall analysis)
Number of subjects: 38803
Study 19719960 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin
Number of subjects: 108
Study 19719960 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release niacin (niacin ER) and atorvastatin
Number of subjects: 108
Study 17353873 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone administered as transdermal gel
Number of subjects: 0
Study 17353873 — intervention group
Group type: EXPERIMENTAL
Intervention: Dehydroepiandrosterone
Number of subjects: 0
Study 17353873 — intervention group
Group type: EXPERIMENTAL
Intervention: New compounds targeting androgen receptors
Number of subjects: 0
Study 14735339 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic hernia repair (small mesh)
Number of subjects: 123
Study 14735339 — intervention group
Group type: COMPARATOR
Intervention: Lichtenstein hernioplasty
Number of subjects: 123
Study 14735339 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic hernia repair
Number of subjects: 123
Study 10383560 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxymetazoline nasal spray (0.9 mg)
Number of subjects: 0
Study 10383560 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 0
Study 8712384 — intervention group
Group type: EXPERIMENTAL
Intervention: General Anesthesia (GA)
Number of subjects: 28
Study 8712384 — intervention group
Group type: COMPARATOR
Intervention: Local Anesthesia (LA)
Number of subjects: 28
Study 1924023 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg of caffeine
Number of subjects: 20
Study 1924023 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 1924023 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 20
Study 6580491 — intervention group
Group type: EXPERIMENTAL
Intervention: Polychemotherapy (mechlorethamine, vincristine, procarbazine, and prednisone)
Number of subjects: 334
Study 6580491 — intervention group
Group type: COMPARATOR
Intervention: No polychemotherapy for relapse
Number of subjects: 334
Study 6580491 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall group (all patients)
Number of subjects: 334
Study 6580491 — intervention group
Group type: EXPERIMENTAL
Intervention: Polychemotherapy after relapse
Number of subjects: 334
Study 6580491 — intervention group
Group type: COMPARATOR
Intervention: No polychemotherapy after relapse
Number of subjects: 334
Study 6580491 — intervention group
Group type: EXPERIMENTAL
Intervention: Polychemotherapy group
Number of subjects: 334
Study 6580491 — intervention group
Group type: COMPARATOR
Intervention: No-relapse group
Number of subjects: 334
Study 6580491 — intervention group
Group type: COMPARATOR
Intervention: No polychemotherapy after relapse group
Number of subjects: 334
Study 31984735 — intervention group
Group type: EXPERIMENTAL
Intervention: HCD containing 9.5% CO (COH)
Number of subjects: 32
Study 31984735 — intervention group
Group type: EXPERIMENTAL
Intervention: HCD containing 4.75% CO (COL)
Number of subjects: 32
Study 31984735 — intervention group
Group type: COMPARATOR
Intervention: HCD
Number of subjects: 32
Study 31984735 — intervention group
Group type: COMPARATOR
Intervention: NCD
Number of subjects: 32
Study 30785406 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile phone-based eHealth program (EH)
Number of subjects: 168
Study 30785406 — intervention group
Group type: COMPARATOR
Intervention: Usual care treatment (UC)
Number of subjects: 168
Study 29428373 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination chemotherapy (paclitaxel 175 mg/m2 and cisplatin 70 mg/m2 for 6 cycles)
Number of subjects: 46
Study 29428373 — intervention group
Group type: COMPARATOR
Intervention: Sequential chemotherapy (paclitaxel for 3 cycles followed by cisplatin for 3 cycles)
Number of subjects: 46
Study 26325671 — intervention group
Group type: EXPERIMENTAL
Intervention: 2014 ISUP grading (grades 1-5)
Number of subjects: 496
Study 26325671 — intervention group
Group type: EXPERIMENTAL
Intervention: 2014 ISUP grading
Number of subjects: 496
Study 26325671 — intervention group
Group type: COMPARATOR
Intervention: 2005 modified Gleason system (MGS)
Number of subjects: 496
Study 23109623 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceramic-on-metal (CoM) total hip replacement
Number of subjects: 83
Study 23109623 — intervention group
Group type: COMPARATOR
Intervention: Metal-on-metal (MoM) total hip replacement
Number of subjects: 83
Study 20531348 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 48
Study 20531348 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 48
Study 18840821 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 13388
Study 18840821 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13388
Study 16055461 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 microg conventional misoprostol
Number of subjects: 31
Study 16055461 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 microg SR misoprostol
Number of subjects: 31
Study 16055461 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 microg SR misoprostol
Number of subjects: 31
Study 12074329 — intervention group
Group type: EXPERIMENTAL
Intervention: FHIG (infusional fluorouracil 2.6 g/m2 over 24 hours once per week for 6 weeks, infusional hydroxyurea 4.3 g/m2 over 24 hours once per week for 6 weeks, interferon-alpha-2a 9 MU subcutaneously three times per week for 6 weeks)
Number of subjects: 29
Study 12074329 — intervention group
Group type: COMPARATOR
Intervention: AD (doxorubicin 50 mg/m2 and docetaxel 75 mg/m2 intravenously every 21 days)
Number of subjects: 29
Study 12074329 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life assessment for FHIG
Number of subjects: 29
Study 10329290 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulus speed of 4 degrees/s in V5
Number of subjects: 0
Study 10329290 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulus speed of 8 degrees/s in V5
Number of subjects: 0
Study 10329290 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulus speed of 4 to 16 degrees/s in V3a
Number of subjects: 0
Study 10329290 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast vs slow speed and color > luminance contrast in V5
Number of subjects: 0
Study 10329290 — intervention group
Group type: EXPERIMENTAL
Intervention: Moving vs stationary motion and color > luminance contrast in V4
Number of subjects: 0
Study 8961505 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGM-CSF (20-40 micrograms, injected at the same site as the vaccine)
Number of subjects: 108
Study 8961505 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 108
Study 1849343 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse practitioner post-visit support
Number of subjects: 190
Study 1849343 — intervention group
Group type: COMPARATOR
Intervention: Usual follow-up advice
Number of subjects: 190
Study 6340275 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine alone
Number of subjects: 47
Study 6340275 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate and amphotericin B
Number of subjects: 47
Study 6340275 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine plus amphotericin B
Number of subjects: 47
Study 29696357 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-acute assessment (8 weeks after first in-patient treatment)
Number of subjects: 72
Study 29696357 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-year follow-up assessment
Number of subjects: 72
Study 29696357 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple regression models
Number of subjects: 72
Study 29696357 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with higher stigma experiences
Number of subjects: 72
Study 29735878 — intervention group
Group type: EXPERIMENTAL
Intervention: Health mentoring program
Number of subjects: 70
Study 29735878 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education program
Number of subjects: 70
Study 29735878 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 70
Study 26960799 — intervention group
Group type: EXPERIMENTAL
Intervention: Third‐ and fourth‐degree anal sphincter tears
Number of subjects: 558
Study 26960799 — intervention group
Group type: COMPARATOR
Intervention: Normal vaginal deliveries (comparison group)
Number of subjects: 558
Study 24268872 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotracheal tube cuff pressure control (study group, n=20)
Number of subjects: 43
Study 24268872 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=23)
Number of subjects: 43
Study 22701555 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to ART (defined as taking 100% of prescribed doses and not interrupting treatment for more than two consecutive days)
Number of subjects: 459
Study 22701555 — intervention group
Group type: COMPARATOR
Intervention: Inconsistent condom use (ICU)
Number of subjects: 459
Study 22701555 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to ART
Number of subjects: 459
Study 20402305 — intervention group
Group type: EXPERIMENTAL
Intervention: Harmonic scalpel
Number of subjects: 61
Study 20402305 — intervention group
Group type: COMPARATOR
Intervention: Monopolar electrocauter
Number of subjects: 61
Study 17556408 — intervention group
Group type: EXPERIMENTAL
Intervention: TAK-044 (100 mg)
Number of subjects: 7
Study 17556408 — intervention group
Group type: EXPERIMENTAL
Intervention: TAK-044 (750 mg)
Number of subjects: 7
Study 17556408 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 18318098 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based health care approach in orthodontics
Number of subjects: 0
Study 14736774 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed combination of latanoprost 0.005% and timolol 0.5% (once daily morning dose)
Number of subjects: 190
Study 14736774 — intervention group
Group type: COMPARATOR
Intervention: Unfixed combination of latanoprost 0.005% (once daily evening) and timolol 0.5% (twice daily)
Number of subjects: 190
Study 14736774 — intervention group
Group type: COMPARATOR
Intervention: Comparison of fixed and unfixed combinations
Number of subjects: 190
Study 10837880 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 108
Study 10837880 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 108
Study 10837880 — intervention group
Group type: COMPARATOR
Intervention: Paroxetine
Number of subjects: 108
Study 10837880 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine, Sertraline, Paroxetine
Number of subjects: 108
Study 9394641 — intervention group
Group type: EXPERIMENTAL
Intervention: Power grasp
Number of subjects: 40
Study 9394641 — intervention group
Group type: EXPERIMENTAL
Intervention: Smooth-rim handwheel in frontal plane
Number of subjects: 40
Study 9394641 — intervention group
Group type: EXPERIMENTAL
Intervention: Counterclockwise torque exertion
Number of subjects: 40
Study 9394641 — intervention group
Group type: EXPERIMENTAL
Intervention: MVTE for women
Number of subjects: 40
Study 1388702 — intervention group
Group type: EXPERIMENTAL
Intervention: Amantadine (0.2 g amantadine‐sulfate in 500 ml NaCl)
Number of subjects: 20
Study 1388702 — intervention group
Group type: COMPARATOR
Intervention: Placebo (500 ml NaCl)
Number of subjects: 20
Study 3911877 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxalactam
Number of subjects: 864
Study 3911877 — intervention group
Group type: COMPARATOR
Intervention: Cefotaxime, Cefoperazone
Number of subjects: 864
Study 31013233 — intervention group
Group type: COMPARATOR
Intervention: Passive strategy consisting of preventive information
Number of subjects: 163
Study 31013233 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive strategy combined with an active component of case management (MAC)
Number of subjects: 163
Study 31013233 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive strategy, case management and a psychoeducational programme (PSyMAC)
Number of subjects: 163
Study 29798502 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual reduction combined with psychological intervention
Number of subjects: 68
Study 29798502 — intervention group
Group type: COMPARATOR
Intervention: Simple manipulation (Control group)
Number of subjects: 68
Study 26485501 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete device removal and antibiotic treatment for six weeks
Number of subjects: 71
Study 24561009 — intervention group
Group type: EXPERIMENTAL
Intervention: CXR-defined apical LV lead position
Number of subjects: 447
Study 24561009 — intervention group
Group type: COMPARATOR
Intervention: MD-determined anterior or apical LV lead position
Number of subjects: 447
Study 24561009 — intervention group
Group type: COMPARATOR
Intervention: CXR-determined anterior LV lead position
Number of subjects: 447
Study 22760902 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous exercise training
Number of subjects: 37
Study 22760902 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval exercise training
Number of subjects: 37
Study 21174567 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% mepivacaine with 1:20,000 levonordefrin
Number of subjects: 60
Study 21174567 — intervention group
Group type: COMPARATOR
Intervention: 2% lidocaine with 1:100,000 epinephrine
Number of subjects: 60
Study 17667128 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous direct anodal microcurrent applied to silver nylon wound contact dressings
Number of subjects: 30
Study 15701763 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist intervention (n = 43) for 6 months followed by 6-month usual-care observation period
Number of subjects: 77
Study 15701763 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n = 34) for 6 months followed by 6-month usual-care observation period
Number of subjects: 77
Study 11942883 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (8 mg sublingually)
Number of subjects: 126
Study 11942883 — intervention group
Group type: COMPARATOR
Intervention: Hydralazine (5-10 mg intravenous)
Number of subjects: 126
Study 9869161 — intervention group
Group type: COMPARATOR
Intervention: FIX‐SD
Number of subjects: 11
Study 9869161 — intervention group
Group type: EXPERIMENTAL
Intervention: FIX‐SD‐15
Number of subjects: 11
Study 9869161 — intervention group
Group type: COMPARATOR
Intervention: FIX‐SD and FIX‐SD‐15
Number of subjects: 11
Study 9869161 — intervention group
Group type: COMPARATOR
Intervention: FIX
Number of subjects: 11
Study 8731830 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulperazone
Number of subjects: 207
Study 8731830 — intervention group
Group type: COMPARATOR
Intervention: Cefotaxime
Number of subjects: 207
Study 2749951 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed-beam (neutron/photon) radiotherapy
Number of subjects: 91
Study 2749951 — intervention group
Group type: COMPARATOR
Intervention: Conventional photon (x-ray) radiotherapy
Number of subjects: 91
Study 132705 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tetracycline preparation
Number of subjects: 135
Study 132705 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tetracycline 0.5 gm daily
Number of subjects: 135
Study 132705 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study 31521872 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant treatment
Number of subjects: 1647
Study 29920177 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-supported ergonomic education (1 face-to-face session + 3 weekly telephone sessions)
Number of subjects: 110
Study 29920177 — intervention group
Group type: COMPARATOR
Intervention: Standard face-to-face ergonomic education (1 session)
Number of subjects: 110
Study 28073039 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep disturbances evaluated using the Leeds Sleep Evaluation Questionnaire (LSEQ) within 2 weeks after ACS.
Number of subjects: 828
Study 28073039 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep disturbances (LSEQ)
Number of subjects: 828
Study 27087103 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus DMTAC
Number of subjects: 76
Study 24101036 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based aftercare intervention
Number of subjects: 334
Study 24101036 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (Control)
Number of subjects: 334
Study 22389047 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine-containing cigarette
Number of subjects: 22
Study 22389047 — intervention group
Group type: COMPARATOR
Intervention: Denicotinized cigarette
Number of subjects: 22
Study 19631853 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct pulp capping
Number of subjects: 0
Study 19631853 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 17449917 — intervention group
Group type: EXPERIMENTAL
Intervention: High-pressure parallel waterjet (n = 12)
Number of subjects: 21
Study 17449917 — intervention group
Group type: COMPARATOR
Intervention: Pulse lavage (n = 9)
Number of subjects: 21
Study 15696244 — intervention group
Group type: EXPERIMENTAL
Intervention: Edifoligide (E2F Decoy) administered to vein grafts in a single, ex vivo treatment following vein harvest and before implantation.
Number of subjects: 1400
Study 15696244 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified in the abstract.
Number of subjects: 1400
Study 12653822 — intervention group
Group type: EXPERIMENTAL
Intervention: exercise counselling
Number of subjects: 299
Study 12653822 — intervention group
Group type: COMPARATOR
Intervention: health education advice
Number of subjects: 299
Study 10547465 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy plus radiation
Number of subjects: 0
Study 8739854 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer patients with solid tumors
Number of subjects: 975